Chiesi Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics BioAtla Announces Pricing of Initial Public Offering 4D Molecular Therapeutics Announces Upsized Pricing of Initial Public Offering Reneo Pharmaceuticals Raises $95 Million in Series B Financing, Co-led by Novo Ventures and Abingworth Mirum Pharmaceuticals Announces European Medicines Agency Validation of the Marketing Authorization Application for Maralixibat in Patients with PFIC2 VelosBio to be Acquired by Merck for $2.75 billion VelosBio Announces First Patient Dosed in Phase 2 Trial of VLS-101 in Solid Tumors Mirum Pharmaceuticals Initiates Rolling Submission of a New Drug Application for Maralixibat Kyle Rasbach will serve on a panel at the World Orphan Drug Congress USA 2020 4D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of 4D-125 by Intravitreal Injection for the Treatment of X-Linked Retinitis Pigmentosa pcopu - June 18, 2018 - No Comments